Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (26)

2024

  1. Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294

2022

  1. Quality of Life Impact of Hypoglossal Nerve Stimulation with Inspire® Device in Patients with Obstructive Sleep Apnea Intolerant to Continuous Positive Airway Pressure Therapy

    Life, Vol. 12, Núm. 11

2021

  1. Aerodynamic Measures in Muscle Tension Dysphonia

    Journal of Voice

2020

  1. Does more compression mean more pressure? A new classification for muscle tension dysphonia

    Journal of Speech, Language, and Hearing Research, Vol. 63, Núm. 7, pp. 2177-2184

2019

  1. Lacrimal diversion devices (sinopsys lacrimal stent): Sharing our experience with patients with chronic rhinosinusitis without polyposis

    International Archives of Otorhinolaryngology, Vol. 23, Núm. 4, pp. 422-426

2015

  1. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome

    Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322

  2. Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited

    Brachytherapy, Vol. 14, Núm. 4, pp. 565-570

2014

  1. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model

    Brachytherapy, Vol. 13, Núm. 4, pp. 400-404

  2. Volume of high-dose regions and likelihood of locoregional control after perioperative high-dose-rate brachytherapy: Do hotter implants work better?

    Brachytherapy, Vol. 13, Núm. 6, pp. 591-596

2012

  1. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

2011

  1. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  2. Identificación de las vías de drenaje linfático y biopsia selectiva de ganglio centinela en un paciente con melanoma amelanocítico de úvula

    Revista Espanola de Medicina Nuclear, Vol. 30, Núm. 5, pp. 325-326

  3. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

2009

  1. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer

    Brachytherapy, Vol. 8, Núm. 1, pp. 26-33

  2. Reconstrucción de defectos faríngeos

    Acta Otorrinolaringologica Espanola, Vol. 60, Núm. 4, pp. 283-290

2008

  1. TAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients

    Gene Regulation and Systems Biology, Vol. 2008, Núm. 2, pp. 63-70

2007

  1. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients

    Oral Oncology, Vol. 43, Núm. 7, pp. 713-719

2006

  1. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study

    Brachytherapy, Vol. 5, Núm. 1, pp. 32-40

2004

  1. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas

    Brachytherapy, Vol. 3, Núm. 4, pp. 196-200

2003

  1. Ewings' sarcoma of the mandible

    Journal of Laryngology and Otology, Vol. 117, Núm. 9, pp. 736-738